Evidence for telomeric fusions as a mechanism for recurring structural aberrations of chromosome 11 in giant cell tumor of bone
- PMID: 15860354
- DOI: 10.1016/j.cancergencyto.2004.09.001
Evidence for telomeric fusions as a mechanism for recurring structural aberrations of chromosome 11 in giant cell tumor of bone
Abstract
Giant cell tumor of bone (GCTB) is a benign but often aggressive tumor with a tendency toward local recurrence. Telomeric associations (tas) or telomeric fusions are common cytogenetic findings that have been implicated in the initiation of chromosome instability and tumorigenesis. We performed cytogenetic studies on 5 cases of GCTB to further characterize chromosome aberrations in these tumors. Four of the 5 cases showed abnormal karyotypes with clonal telomeric fusions involving chromosome 11. In 3 cases, the telomeric fusions of 11pter were apparently the precursor lesions to the progression of sub-clones with structural chromosome aberrations of 11p. Two tumors demonstrated a similar pattern of progression resulting in whole arm losses of 11p, including sub-clones with both whole-arm unbalanced translocations and whole-arm deletions. A third tumor with clonal tas of 11pter showed 2 additional subclones, one with ring chromosome 11 and the other with an extra copy of 1q. To our knowledge, the 2 cases with del(11)(p11) represent the first report of a recurring structural chromosome aberration in GCTB. These findings support the concept that telomeric instability is responsible for a large degree of intratumor heterogeneity and serves as a precursor lesion to subsequent clonal structural aberrations of chromosome 11 in GCTB.
Similar articles
-
Cytogenetic analysis of 101 giant cell tumors of bone: nonrandom patterns of telomeric associations and other structural aberrations.Genes Chromosomes Cancer. 2009 Jul;48(7):583-602. doi: 10.1002/gcc.20667. Genes Chromosomes Cancer. 2009. PMID: 19396867
-
A role for telomeric and centromeric instability in the progression of chromosome aberrations in meningioma patients.Cancer. 2000 Jan 15;88(2):440-53. Cancer. 2000. PMID: 10640979
-
Cytogenetic analyses on giant-cell tumors of bone.Clin Orthop Relat Res. 1989 Mar;(240):250-60. Clin Orthop Relat Res. 1989. PMID: 2917441
-
Giant cell tumor of bone. Chromosomal analysis of 48 specimens and review of the literature.Cancer Genet Cytogenet. 1992 Jan;58(1):2-13. doi: 10.1016/0165-4608(92)90125-r. Cancer Genet Cytogenet. 1992. PMID: 1728946 Review.
-
Telomere length heterogeneity and chromosome instability.Cancer Lett. 2004 Aug 30;212(2):135-44. doi: 10.1016/j.canlet.2004.05.008. Cancer Lett. 2004. PMID: 15341022 Review.
Cited by
-
p63 regulates cell proliferation and cell cycle progression‑associated genes in stromal cells of giant cell tumor of the bone.Int J Oncol. 2013 Feb;42(2):437-43. doi: 10.3892/ijo.2012.1727. Epub 2012 Dec 3. Int J Oncol. 2013. PMID: 23229819 Free PMC article.
-
Centromere fission, not telomere erosion, triggers chromosomal instability in human carcinomas.Carcinogenesis. 2011 Jun;32(6):796-803. doi: 10.1093/carcin/bgr069. Epub 2011 Apr 8. Carcinogenesis. 2011. PMID: 21478459 Free PMC article. Review.
-
Giant cell tumour of bone: morphological, biological and histogenetical aspects.Int Orthop. 2006 Dec;30(6):484-9. doi: 10.1007/s00264-006-0215-7. Epub 2006 Sep 30. Int Orthop. 2006. PMID: 17013643 Free PMC article. Review.
-
Giant cell tumor of bone: a neoplasm or a reactive condition?Int J Clin Exp Pathol. 2008 Jan 1;1(6):489-501. Int J Clin Exp Pathol. 2008. PMID: 18787633 Free PMC article.
-
Prognosis of local recurrence in giant cell tumour of bone: what can we do?Radiol Med. 2017 Jul;122(7):505-519. doi: 10.1007/s11547-017-0746-6. Epub 2017 Mar 7. Radiol Med. 2017. PMID: 28271361 Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical